×
0 0 0 0 0 0 0 0
Stockreport

Celgene ups dose and enrollment in mid-stage study of bb2121 in multiple myeloma [Seeking Alpha]

CELGENE (CELG)  More Company Research Source: Seeking Alpha
Last celgene earnings: 7/26 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celgene.com
PDF Celgene ups dose and enrollment in mid-stage study of bb2121 in multiple myelomaCiting the totality of the clinical data, Celgene (NASDAQ:CELG) hasamended the protocol in its Phase 2 clinical trial,KarMMa, assessing CAR T candidate bb2121 in patients with relapsed/refractory multiple myeloma (MM).Specifically, the dose range has been increased to 15 - 45 x 107 CAR T-cells from 15 - 30 x 107 cells. Also, the enrollment target has been increased to up to 140 subjects.It has also amended the protocol in its Phase 1 study, CRB-401, evaluating bb2121 in relapsed/refractory MM. Enrollment will be increased by up to 20 subjects and the dose range will be the same as KarMMa.Celgene and licensor bluebird bio (NASDAQ:BLUE) continue to expect regulatory approval for bb2121 in MM in 2020.CELG is up a fraction and BLUE is down a fraction after hours.Previously:Celgene and bluebird bio team up to develop and commercialize CAR T bb2121 (March 28)Previously:Celgene launches mid-stage study of CAR-T c [Read more]

IMPACT SNAPSHOT EVENT TIME: CELG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CELG alerts

from News Quantified
Opt-in for
CELG alerts

from News Quantified